PEAK6
LLY icon

PEAK6’s Eli Lilly LLY Stock Holding History

PEAK6’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$138M Sell
150,500
-172,300
-53% -$175M 0.32% 55
2025
Q4 		$347M Buy
322,800
+51,500
+19% +$49.2M 0.65% 34
2025
Q3 		$207M Buy
271,300
+79,600
+42% +$59.2M 0.3% 66
2025
Q2 		$149M Buy
191,700
+25,200
+15% +$19.6M 0.28% 72
2025
Q1 		$138M Sell
166,500
-105,200
-39% -$87.5M 0.31% 68
2024
Q4 		$210M Buy
+271,700
New +$225M 0.44% 44

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

PEAK6's LLY Position: Q1 2026 in Review

PEAK6 reduced its Eli Lilly (LLY) stake by 33% in Q1 2026, selling an estimated $1.01K and leaving 2 shares worth $2.07K. The position accounts for ﹤0.01% of the portfolio, ranked #2570.

PEAK6 first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $15.7M in Q1 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • PEAK6 held 2 shares of Eli Lilly worth $2.07K as of Q1 2026.
  • PEAK6 sold 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up ﹤0.01% of PEAK6's portfolio in Q1 2026, its #2570 holding.
  • PEAK6 first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • PEAK6's Eli Lilly position peaked at $15.7M in Q1 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.